Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Frontiers in Drug Safety and Regulation|September 22, 2025
External Comparator Cohort studies - clarification of terminologyGerd Rippin, Joan Largent, Wilhelmina Elisabeth Hoogendoorn, et al.Virchows Archiv : an International Journal of Pathology|January 30, 2004
Quantitative morphometric analysis of the submucous plexus in age-related control groupsWiltrud Coerdt, Jörg-S Michel, Gerd Rippin, et al.The American Journal of Cardiology|January 10, 2002
Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery diseaseChristoph Bickel, Hans J Rupprecht, Stefan Blankenberg, et al.High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|March 29, 2020
Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-AnalysisBurkhard Weisser, Hans-Georg Predel, Anton Gillessen, et al.Journal of Comparative Effectiveness Research|February 4, 2026
Sieving for gold: external comparator studies to prioritize drugs for late-stage clinical trialSamuel Vennin, Will Sopwith, Emiliano Calvo, et al.International Journal of Cardiology|January 12, 2002
Influence of HMG-CoA reductase inhibitors on markers of coagulation, systemic inflammation and soluble cell adhesionChristoph Bickel, Hans J Rupprecht, Stefan Blankenberg, et al.Circulation|January 5, 2002
Impact of infectious burden on extent and long-term prognosis of atherosclerosisChristine Espinola-Klein, Hans J Rupprecht, Stefan Blankenberg, et al.Chest|August 12, 2008
A Search for subgroups of patients with ARDS who may benefit from surfactant replacement therapy: a pooled analysis of five studies with recombinant surfactant protein-C surfactant (Venticute)Friedemann J H Taut, Gerd Rippin, Peter Schenk, et al.The American Journal of Cardiology|April 13, 2002
Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery diseaseChristoph Bickel, Hans J Rupprecht, Stefan Blankenberg, et al.Drug Safety|August 5, 2024
Examining the Effect of Missing Data and Unmeasured Confounding on External Comparator Studies: Case Studies and SimulationsGerd Rippin, Héctor Sanz, Wilhelmina E Hoogendoorn, et al.Pageof 3